Biogen, Inc. (BIIB)
175.61
+3.27
(+1.90%)
USD |
NASDAQ |
Apr 07, 16:00
176.80
+1.19
(+0.68%)
After-Hours: 20:00
Biogen Cash from Investing (TTM) : -1.371B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amgen, Inc. | -1.943B |
| Gilead Sciences, Inc. | -4.793B |
| Eli Lilly & Co. | -10.97B |
| Merck & Co., Inc. | -13.74B |
| Apellis Pharmaceuticals, Inc. | -0.313M |